UNSPSC 51373327: Aspirin/codeine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373327 Aspirin/codeine is a Commodity code that encompasses pharmaceutical products—specifically generic and branded pain relievers, opioid combinations, and over-the-counter medications—that state and local health agencies, counties, and cooperative purchasing alliances procure for distribution through their health systems, community health programs, and emergency response initiatives. The scope of work actually being solicited differs materially from the code's nominal title: recent opportunities show state and local buyers acquiring naloxone and drug deactivation systems for community health and opioid-response initiatives, generic multi-source pharmaceuticals through cooperative purchasing vehicles, and exploring direct-to-manufacturer prescription fulfillment models to reduce costs and improve dispensing efficiency. Issuing bodies span county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, which serves participating jurisdictions including Oregon). These solicitations reflect a shift toward emergency medication procurement, generic pharmaceutical supply-chain optimization, and alternative contracting models outside traditional pharmacy benefit managers.

Recent activity concentrates in Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023 (note: this date appears erroneous in the source). The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescription program, a preliminary market intelligence solicitation with no formal award timeline. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 on January 20, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026; this cooperative purchasing vehicle serves state and local government facilities across multiple jurisdictions. Pricing in the MMCAP procurement is weighted 75 percent toward competitiveness, with compliance, EDI capability, and administrative fee acceptance comprising the remainder; vendors must maintain relationships with authorized wholesalers and comply with cGMP and Drug Supply Chain Security Act certification requirements.